CHIARAVALLOTI, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 26.138
AS - Asia 5.390
EU - Europa 3.604
SA - Sud America 599
AF - Africa 82
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 35.836
Nazione #
US - Stati Uniti d'America 26.012
SG - Singapore 3.375
IT - Italia 806
CN - Cina 679
DE - Germania 622
RU - Federazione Russa 601
BR - Brasile 503
VN - Vietnam 431
HK - Hong Kong 416
IE - Irlanda 314
GB - Regno Unito 254
FR - Francia 253
UA - Ucraina 246
JP - Giappone 137
SE - Svezia 137
FI - Finlandia 103
CA - Canada 76
IN - India 58
KR - Corea 58
PL - Polonia 52
NL - Olanda 48
AT - Austria 45
ID - Indonesia 40
AR - Argentina 38
ZA - Sudafrica 34
BD - Bangladesh 32
MX - Messico 31
ES - Italia 25
IQ - Iraq 22
TR - Turchia 20
CZ - Repubblica Ceca 19
UZ - Uzbekistan 19
EC - Ecuador 15
PK - Pakistan 13
CO - Colombia 12
LT - Lituania 10
MA - Marocco 10
PH - Filippine 10
SA - Arabia Saudita 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
EU - Europa 9
JO - Giordania 9
AU - Australia 8
BE - Belgio 8
KE - Kenya 8
PY - Paraguay 8
AL - Albania 7
CL - Cile 7
DK - Danimarca 7
ET - Etiopia 7
IR - Iran 7
KG - Kirghizistan 7
NO - Norvegia 7
RO - Romania 7
DZ - Algeria 6
GR - Grecia 6
AZ - Azerbaigian 5
EG - Egitto 5
GE - Georgia 4
IL - Israele 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
BG - Bulgaria 3
HR - Croazia 3
JM - Giamaica 3
KH - Cambogia 3
MY - Malesia 3
TH - Thailandia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
CR - Costa Rica 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BM - Bermuda 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GY - Guiana 1
KW - Kuwait 1
MD - Moldavia 1
MK - Macedonia 1
Totale 35.826
Città #
Wilmington 7.323
Houston 5.762
Woodbridge 5.593
Singapore 1.067
Fairfield 745
Chandler 612
Ashburn 597
San Jose 514
Ann Arbor 438
Hong Kong 413
Seattle 331
Rome 325
Beijing 315
Dublin 298
New York 270
Cambridge 228
Medford 214
Jacksonville 209
Dearborn 184
The Dalles 162
Santa Clara 154
Los Angeles 142
Moscow 136
Ho Chi Minh City 133
Tokyo 126
Council Bluffs 112
Hanoi 102
Lawrence 99
Boardman 97
Lauterbourg 97
Buffalo 73
São Paulo 70
Dallas 66
Munich 58
San Diego 49
Menlo Park 42
Chicago 38
Nuremberg 37
Helsinki 34
Atlanta 33
London 33
Warsaw 33
North Bergen 32
Redondo Beach 32
Milan 31
Jakarta 29
Phoenix 29
Orem 28
Montreal 26
Redwood City 24
Toronto 24
Creede 23
Stockholm 23
San Francisco 22
Vienna 21
Johannesburg 20
Washington 20
Denver 19
Kunming 19
Brooklyn 18
Tashkent 18
Belo Horizonte 17
Chennai 17
Kraków 17
Nanjing 17
Poplar 17
Frankfurt am Main 16
Guangzhou 16
Manchester 16
Palo Alto 16
Naples 15
Norwalk 15
Brno 14
Da Nang 14
Rio de Janeiro 14
Amsterdam 13
Biên Hòa 13
Haiphong 13
Columbus 12
Mülheim 12
Bologna 11
Lappeenranta 11
Baghdad 10
Detroit 10
Dong Ket 10
Hải Dương 10
Paris 10
Salt Lake City 10
Turin 10
Turku 10
Bari 9
Mumbai 9
Verona 9
Boston 8
Bắc Ninh 8
City of London 8
Curitiba 8
Hefei 8
Mexico City 8
Monte Porzio Catone 8
Totale 28.291
Nome #
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT 586
Usefulness of 18F Florbetaben in diagnosis of Alzheimer's disease and other types of dementia 516
18F FDOPA uptake in brain metastasis of breast cancer 499
111In-pentetreotide SPECT/CT in pulmonary carcinoid 494
Do CSF levels of t-Tau, p-Tau and beta(1-42) amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A I-123-FP-CIT study in the early stages of the disease 488
Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms 484
Studio del metabolismo cerebrale in corso di stimolo olfattivo nella Sindrome da Sensibilità Chimica Multipla: dalla (dis)percezione olfattoria al correlato neurobiologico 481
18F-choline PET/CT pitfalls in image interpretation: An update on 300 examined patients with prostate cancer 478
Comparison of 18F FDOPA PET, DSC-MRI and spectroscopy in a patient with brain metastatic lesions from lung cancer 476
A case of intracranial meningioma detected by 18F-choline PET/CT and examined by PET/MRI fusion imaging 471
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease 466
Cortical activity during olfactory stimulation in multiple chemical sensitivity: a 18F-FDG PET/CT study 446
Factors affecting intrapatient liver and mediastinal blood pool 18F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma 446
18F-FDG PET/MR in herpes simplex virus encephalitis: A case study 445
WIDEN: A tool for medical image management in multicenter clinical trials 444
Involvement of Subcortical Brain Structures During Olfactory Stimulation in Multiple Chemical Sensitivity 440
Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early 18F-FCH PET/CT? 438
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 435
Chronic obstructive pulmonary disease (COPD) patients with osteoporotic vertebral compression fractures (OVCFs): improvement of pulmonary function after percutaneous vertebroplasty (VTP) 432
Decoupled association between 18F-FDG and 18F-FDOPA uptake in a carcinoid of the thymus 430
Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin's lymphoma? 427
Factors affecting 18F FDOPA standardized uptake value in patients with primary brain tumors after treatment 424
Thalamic ¹²³I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression 423
Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin's lymphoma: the total amount of uptake may play a role in the inverse relationship 423
Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT 420
Cerebellar metabolic involvement and its correlations with clinical parameters in vestibular neuritis. 418
Evaluation of recurrent disease in the re-staging of colorectal cancer by 18F-FDG PET/CT: Use of CEA and CA 19-9 in patient selection. 415
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG. 406
Cortical 18F FDG-PET changes during olfactory stimulation in normal subjects 403
Functional correlates of t-Tau, p-Tau and Aβ1-42 amyloid cerebrospinal fluid levels in Alzheimer's disease: A 18F-FDG PET/CT study 392
Brain metabolic changes in hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT study 384
PET Probe-guided surgery in patients with breast cancer: Proposal for a methodological approach 383
Cortical Involvement in Unilateral Vestibular Deficit: Early Metabolic Changes 382
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 380
Cortical metabolic changes in vestibular neurutis detected by 18F-FDG PET/CT 379
Reverse perfusion pattern in myocardial spect with 99mTc-sestaMIBI. 378
Cortical 18F FDG-PET changes during olfactory stimulation in normal subjects 376
PICASO: a personalised integrated care platform 375
Low-dose CT and contrast-medium CT in hybrid PET/CT systems for oncologic patients 374
When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer's disease from late-life depression 374
Cortical metabolic arrangement during olfactory processing: Proposal for a 18F FDG PET/CT methodological approach 366
cerebellar metabolic involvement and its correlations with clinical parameters in vestibular neuritis: “tor vergata” university experience 359
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma 359
Il coinvolgimento corticale nel deficit vestibolare acuto 352
Transient parkinsonism after unilateral midbrain stroke: a compensatory intervention from the healthy side? 351
Does123I-MIBG scintigraphy really assist the diagnosis of Parkinson's disease? 351
Early and phasic cortical metabolic changes in vesibular neuritis onset 345
New acquisition of cerbral metabolic neural pathways related to olfactory stimulation 341
Initial staging of hodgkin's disease: Role of contrast-enhanced 18F FDG PET/CT 338
Molecular imaging in pediatric brain tumors 336
Metabolic and electrophysiological changes associated to clinical improvement in two severely traumatized subjects treated with EMDR-A pilot study 328
Early cortical responses during vestibular neuritis 325
18F-DOPA PET/CT and MRI findings in a patient with multiple meningiomas 325
Dopaminergic involvement in a drummer with focal dystonia: A case study 323
Cortico-subcortical metabolic correlates of olfactory processing in healthy reasting subjects 320
Cortical metabolic changes in vestibular neuritis detected by 18F-FDG PET/CT 320
Aspects of cerebral plasticity related to clinical features in acute vestibular neuritis: A “starting point” review from neuroimaging studies|La plasticità cerebrale correlata alle caratteristiche cliniche nella neuronite vestibolare acuta: Una revisione della letteratura di neuroimaging 320
18F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease 316
A patient with a benign and a malignant primary pulmonary meningioma: An evaluation with 18F fluorodeoxyglucose positron emission tomography/computed tomography and computed tomography with iodinated contrast 313
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: A F-18 FDG PET/CT study 313
PET/CT with 18F–choline: Physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients: 18F–choline PET/CT bio-distribution and pitfalls. A southern Italian experience 312
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 311
Quantitative analysis of basal and interim PET/CT images for predicting tumor recurrence in patients with Hodgkin's lymphoma 311
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 311
Correction to: Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid (Annals of Nuclear Medicine, (2018), 32, 1, (7-15), 10.1007/s12149-017-1213-0) 304
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study 300
A rare case of primary uterine non-hodgkins's lymphoma with involvement of right ovary: Staging with 18F FDG PET/CT and iodinated contrast CT 296
Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid 293
Ageing effect on 18 F-DOPA and 123 I-MIBG uptake: A cross-sectional study 291
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 289
Early cortical metabolic rearrangement related to clinical data in idiopathic sudden sensorineural hearing loss 284
Coupled Imaging with [ 18 F]FBB and [ 18 F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain 274
Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients? 265
Evaluation of the usefulness of FDG-PET/CT for nodal staging of breast cancer 260
18F-dopa pet/ct physiological distribution and pitfalls: Experience in 215 patients 251
Impact of awake breast cancer surgery on postoperative lymphocyte responses 251
Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine 235
PET/CT with 18F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection? 234
Cerebral metabolic changes related to clinical parameters in idiopathic anosmic patients during olfactory stimulation: a pilot investigation 230
Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study 226
Rearfoot Transcutaneous Oximetry is a Useful Tool to Highlight Ischemia of the Heel 223
The role of epsilon phenotype in brain glucose consumption in Alzheimer’s disease 215
Thalamic 123I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression 210
Brain glucose consumption abnormalities in neuro-Behçet's disease: a preliminary 18F-FDG PET/CT study 210
Theragnostic aspects and radioimmunotherapy in pediatric tumors 206
Evaluation of Task-Related Brain Activity: Is There a Role for 18F FDG-PET Imaging? 203
Subependymal spread of glioblastoma multiforme in positron emission tomography/computed tomography 202
Radiotheranostic Agents Targeting Neuroblastoma: State-of-the-Art and Emerging Perspectives 195
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer 192
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 186
Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial 174
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 165
Long-term follow-up of endovascular treatment of renal artery aneurysms with covered stent deployment 144
18f-fdopa pet/ct suv-derived indices and volumetric parameters correlation in patients with primary brain tumors 133
Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency 128
10-Year clinical experience with 18F-choline PET/CT: an Italian multicenter retrospective assessment of 3343 patients 120
[18F] FBB cortical uptake is not related to the age of onset of Alzheimer’s disease 117
18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study 116
The brain metabolic correlates of the main indices of neuropsychological assessment in Alzheimer’s disease 106
Association between hearing sensitivity and dopamine transporter availability in Parkinson's disease 106
Totale 32.911
Categoria #
all - tutte 95.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021220 0 0 0 0 0 0 0 0 0 0 153 67
2021/20221.041 52 76 132 69 19 74 37 65 61 74 71 311
2022/20231.543 157 139 104 151 110 293 132 178 131 36 69 43
2023/2024827 68 23 51 20 82 233 21 30 13 30 22 234
2024/20254.701 99 626 262 213 222 228 238 181 377 237 1.118 900
2025/20265.371 578 243 603 500 565 192 759 717 548 549 117 0
Totale 36.384